Lead Paint Lawsuit Over Government Cleanup Costs Goes to Trial in CA
Trial began this week for a lawsuit brought by several California municipalities against paint manufacturers, seeking nearly $1 billion in damages to pay for costs associated with lead paint removal from homes, which experts say could place children at risk for developmental delays, brain damage and other problems associated with lead poisoning.
Ten California cities and counties are suing five paint manufacturers, including Sherwin-Williams, alleging that the companies ignored health risks associated with lead paint used in about 5 million homes.
In a trial that began on Monday, the manufacturers are expected to argue that the paint is no longer a significant risk and generally deny the allegations that they knew about the risks long before lead paint was removed from the market in the late 1970s.
Learn More About
Children diagnosed with lead poisoning after exposure to peeling or chipping lead paint in a rental home may be entitled to financial compensation and benefits.Learn More About this Lawsuit
The case is before Santa Clara County Superior Court Judge James Kleinberg, who will render the verdict. It was originally filed 13 years ago, but will proceed to trial following an appeals court decision.
Counties and cities that are a party to the lawsuit include the cities of San Diego and Oakland, and Los Angeles and San Francisco counties, among others.
Lead paint exposure has been linked to developmental problems in children and may even lower IQ. Other side effects of lead poisoning can include injury to the nervous system, seizures, growth or mental retardation, coma and death.
One of the most common causes of lead poisoning in the United States is lead based paint, which was banned in this country in 1978 due to the risk of severe and permanent brain damage it posed, especially among children.
Lead paint is still found in many old homes and in public housing in many urban areas. Approximately half a million children have blood lead levels between 1 and 5 mcg/dl, which the U.S. Centers for Disease Control and Prevention considers unsafe.
"*" indicates required fields
More Top Stories
The FDA has announced it has received 106,000 medical device reports linked to recalled Philips CPAP devices, including nearly 400 deaths.
The U.S. JPML has consolidated all Tepezza lawsuits over hearing loss before one Northern Illinois federal judge for coordinated pretrial proceedings.
Bard claims two cases selected for the third and fourth bellwether trials are no longer representative of the litigation due to the plaintiffs' worsening injuries and need for additional surgeries due to their failed hernia mesh products.